Acta Laser Biology Sinica, Volume. 33, Issue 4, 377(2024)

Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury

DONG Jianglong1、*, SONG Wanjun1, SHAN Xin1, and TONG Yefeng2
Author Affiliations
  • 1The Third Hospital of Hebei Medical University Department of Anesthesia I, Shijiazhuang 050051, China
  • 2The Third Hospital of Hebei Medical University Department of Anesthesia II, Shijiazhuang 050051, China
  • show less
    References(11)

    [1] [1] DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterology Clinics of North America, 2020, 49(4): 643-654.

    [2] [2] KAENKUMCHORN T, WAHBEH G. Ulcerative colitis: making the diagnosiss[J]. Gastroenterology Clinics of North America, 2020, 49(4): 655-669.

    [3] [3] TASBIHGOU S, BARENDS C, ABSALOM A, et al. The role of dexmedetomidine in neurosurgery[J]. Best Practice & Research-Clinical Anaesthesiology, 2021, 35(2): 221-229.

    [6] [6] LIU B, PIAO X, NIU W, et al. Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K/AKT/NF-B oxidative and inflammatory signaling and gut microbiota[J]. Frontiers in Pharmacology, 2020, 11: 1036.

    [7] [7] ZHAO Y, FENG X, LI B, et al. Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K/AKT/mTOR pathway[J]. Frontiers in Pharmacology, 2020, 11: 128.

    [11] [11] SMILLIE C, BITON M, SULLIVAN K, et al. Intra-and inter-cellular rewiring of the human colon during ulcerative colitis[J]. Cell, 2019, 178(3): 714-730.

    [12] [12] REN M, GU M, ZHOU X, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis[J]. World Journal of Gastroenterology, 2019, 25(38): 5800-5813.

    [13] [13] KEATING G. Dexmedetomidine: a review of its use for sedation in the intensive care setting[J]. Drugs, 2015, 75(10): 1119-1130.

    [16] [16] SUN X, CHEN L, HE Z, et al. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease[J]. Current Drug Metabolism, 2019; 20(4): 301-304.

    [17] [17] LI M, LUO H, WU X, et al. Anti-Inflammatory effects of huangqin decoction on dextran sulfate sodium-induced ulcerative colitis in mice through regulation of the gut microbiota and suppression of the Ras-PI3K-Akt-HIF-1 and NF-B pathways[J]. Frontiers in Pharmacology, 2020, 10: 1552.

    [18] [18] SHI L, GUO C, XIE Y, et al. Dexmedetomidine attenuates lung injury in obstructive jaundice rats through PI3K/Akt/HIF-1 signaling pathway[J]. Archives of Medical Research, 2019, 50(5): 233-240.

    Tools

    Get Citation

    Copy Citation Text

    DONG Jianglong, SONG Wanjun, SHAN Xin, TONG Yefeng. Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury[J]. Acta Laser Biology Sinica, 2024, 33(4): 377

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Oct. 23, 2023

    Accepted: Dec. 20, 2024

    Published Online: Dec. 20, 2024

    The Author Email: Jianglong DONG (dong13131139331@163.com)

    DOI:10.3969/j.issn.1007-7146.2024.04.010

    Topics